
Medico Remedies Ltd is Rated Sell
2026-11-19 10:10:57Medico Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Medico Remedies Ltd Falls to 52-Week Low of Rs 18.22 Amidst Prolonged Downtrend
2026-11-06 11:14:02A sustained decline has pushed Medico Remedies Ltd to a fresh 52-week low of Rs 18.22 on 6 Nov 2026, marking a 63.17% drop over the past year despite the broader market showing resilience.
Read More
Medico Remedies Ltd Falls to 52-Week Low of Rs 19 as Sell-Off Deepens
2026-10-28 11:37:29For the fifth consecutive session, Medico Remedies Ltd closed lower, breaching its 52-week low at Rs 19 on 28 Oct 2026, marking a 6.4% decline intraday despite opening with a modest gain. This persistent downward pressure has dragged the stock down by over 61% in the past year, significantly underperforming the broader Sensex, which itself is nearing its own 52-week low.
Read More
Medico Remedies Ltd is Rated Sell
2026-10-27 10:11:20Medico Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 September 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 27 October 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read More
Medico Remedies Ltd Falls to 52-Week Low of Rs 20.5 as Sell-Off Deepens
2026-10-22 12:38:57For the sixth consecutive session, Medico Remedies Ltd has closed lower, culminating in a fresh 52-week low of Rs 20.5 on 22 Oct 2026. This marks a 9.21% decline over the past six days, underscoring sustained selling pressure despite some positive financial indicators.
Read More
Medico Remedies Ltd is Rated Sell
2026-10-16 10:11:10Medico Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 September 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 16 October 2026, providing investors with the latest insights into the company’s performance and outlook.
Read MoreMedico Remedies Gains 4.12%: Valuation Shift and 52-Week Low Mark Key Week
2026-10-10 13:00:33Key Events This Week 05 Oct: Valuation upgrade signals renewed price attractiveness 09 Oct: Stock falls to 52-week low of Rs.20.52 amid continued downtrend 09 Oct: Week closes at Rs.22.73 (+4.12%) outperforming Sensex Week OpenRs.21.83 Week CloseRs.22.73+4.12% <div c...
Read More
Medico Remedies Ltd is Rated Sell
2026-10-05 10:10:51Medico Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 October 2026, providing investors with the most recent and relevant data to assess the company’s outlook.
Read More
Medico Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges
2026-10-05 08:04:16Medico Remedies Ltd has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite ongoing sector headwinds and a challenging price performance relative to the broader market. This repositioning reflects a notable improvement in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the micro-cap pharmaceutical player as a compelling value proposition within its peer group.
Read MoreFinancial Results For Quarter Ended 30Th September 2026.
09-Nov-2026 | Source : BSEUnaudited Standalone Financial Results for Quarter ended 30th September 2026 along with Auditors limited review report.
Board Meeting Outcome for Intimation Under Regulation 30 (Read With Part A Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations)
09-Nov-2026 | Source : BSE1.Unaudited Standalone Financial Results for the quarter ended 30th September 2026 alongwith Auditors
Board Meeting Intimation for Quarterly Financial Results
03-Nov-2026 | Source : BSEMedico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2026 inter alia to consider and approve To consider and approve Unaudited Financial Results for the quarter ended 30th September2026 along with the Limited Review Report thereon.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
Medico Remedies Ltd has announced 2:10 stock split, ex-date: 16 Mar 23
Medico Remedies Ltd has announced 3:1 bonus issue, ex-date: 16 Nov 21
No Rights history available